FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma. Issue 2 (10th November 2021) - Adib, Elio; El‐Zarif, Talal; Jain, Rohit K.; Skelton, William P.; Freeman, Dory; Curran, Catherine; Akl, Elie W.; Nassar, Amin H.; Ravi, Praful; Mantia, Charlene; Kwiatkowski, David J.; Choueiri, Toni K.; et al.